Molecular Biology of Preinvasive and Invasive Breast Tumors
Authors:
Michal Zikán 1
; D. Pavlišta 1
; Z. Velenská 2; D. Cibula 1
Authors‘ workplace:
Onkogynekologické centrum, Gynekologicko-porodnická klinika 1. LF UK a VFN, Praha, přednosta prof. MUDr. A. Martan, DrSc.
1; Ústav patologie 1. LF UK a VFN, Praha, přednosta prof. MUDr. C. Povýšil, DrSc.
2
Published in:
Ceska Gynekol 2008; 73(6): 351-355
Overview
Objective:
To present an overview of molecular characteristics and differences of and between preinvasive and invasive breast tumors.
Design:
Review.
Setting:
Oncogynecologic center, Clinic of Obstetrics and Gynecology, First Faculty of Medicine, Charles University in Prague and General Teaching Hospital, Prague.
Material and methods:
Review of literature.
Conclusion:
Identification of genetic and epigenetic changes in preinvasive and invasive breast tumors can help to better classify these lesions and improve and tailor their clinical management. Due to completely different biological behavior of morphologically identical lesions, it is clear that the matter of classification and clarification of their clinical behavior is hidden inside the entire genome or proteome.
Key words:
breast cancer, DCIS, LCIS.
Sources
1. Claus, EB., Stowe, M., Carter, D. Family history of breast and ovarian cancer and the risk of breast carcinoma in situ. Breast Cancer Res Treat, 2003, 78, 1, p. 7-15.
2. Farabegoli, F., Champeme, MH., Bieche, I., et al. Genetic pathways in the evolution of breast ductal carcinoma in situ. J Pathol, 2002, 196, p. 280-286.
3. Hieken, TJ., Farolan, M., D’Alessandro, S., et al. Predicting the biologic behavior of ductal carcinoma in situ: an analysis of molecular markers. Surgery, 2001, 130, p. 593-600.
4. Jacobs, EJ., Feigelson, HS., Bain, EB., et al. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res, 2006, 8, p. R22.
5. Kataoka, N., Cai, Q., Wen, W., et al. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women. Cancer Epidemiol Biomarkers Prev, 2006, 15, p. 1148-1152.
6. Kepple, J., Henry-Tillman, RS., Klimberg, VS., et al. The receptor expression pattern in ductal carcinoma in situ predicts recurrence. Am J Surg, 2006, 192, p. 68-71.
7. Lee, S., Mohsin, SK., Mao, S., et al. Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer. Breast Cancer Res, 2006, 8, R6.
8. Leong, AS., Sormunen, RT., Vinyuvat, S., et al. Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma. A comparison of eight contemporary grading systems. Am J Clin Pathol, 2001, 115, p. 709-718.
9. Papantoniou, V., Tsiouris, S., Koutsikos, J., et al. Scintimammographic detection of usual ductal breast hyperplasia with increased proliferation rate at risk for malignancy. Nucl Med Commun, 2006, 27, p. 911-917.
10. Perou, CM., Sorlie, T., Eisen, MB., et al. Molecular portraits of human breast tumours. Nature, 2000, 40, 6, p. 747-752.
11. Pinder, SE., Ellis, IO. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)-current definitions and classification. Breast Cancer Res, 2003, 5, p. 254-257.
12. Polyak, K. Breast cancer: origins and evolution. J Clin Incest, 2007, 117, p. 3155-3163.
13. Purushotham, AD. The diagnosis and management of pre-invasive breast disease: problems associated with management of pre-invasive lesions. Breast Cancer Res, 2003, 5, p. 309-312.
14. Reis-Filho, JS., Lakhani, SR. The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res, 2003, 5, p. 313-319.
15. Smith, KL., Adank, M., Kauff, N., et al. BRCA mutations in women with ductal carcinoma in situ. Clin Cancer Res, 2007, 13, 14, p. 4306-4310.
16. Sofie, T., Perou, CM., Tibshirani, R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. PNAS, 2001, 98, 19, p. 10869-10874.
17. Van de Vijver, MJ., Peterse, H. The diagnosis and management of pre-invasive breast disease: pathological diagnosis – problems with existing classifications. Breast Cancer Res, 2003, 5, p. 269.
18. Viacava, P., Naccarato, AG., Bocci, G., et al. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast. J Pathol, 2004, 204, p. 140-146.
19. Vogl, G., Dietze, O., Hauser-Kronberger, C. Angiogenic potential of ductal carcinoma in situ (DCIS) of human breast. Histopathology, 2005, 47, p. 617-624.
Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicineArticle was published in
Czech Gynaecology
2008 Issue 6
Most read in this issue
- Dilemma of the Results Interpretation of Molecular Genetic Analysis with a Focus on CFTR Gene Mutations in Men with Reproductive Disorders and in Gamete Donors
- Validity of Hysteroscopy in Clinical Setting: Single Centre Analysis of 605 Consecutive Hysteroscopies
- The Clinical Significance of Sentinel Lymph Node Micrometastases in Breast Cancer
- Molecular Biology of Preinvasive and Invasive Breast Tumors